Do you want to read an article? Please log in or register.
De-escalating rituximab dose results in stability of clinical, radiological, and serum neurofilament levels in multiple sclerosis
Multiple Sclerosis
Related content
RECOMMENDED
Multiple Sclerosis
Serum neurofilament light chain level associations with clinical and cognitive performance in multiple sclerosis: A longitudinal retrospective 5-year study
★ 3
Recommended by
Prof. Dr Christian Kamm, Faculty Member
Mult Scler.
Jakimovski D, Zivadinov R, Ramanthan M, Hagemeier J, Weinstock-Guttman B, Tomic D, Kropshofer H, Fuchs TA, Barro C, Leppert D, Yaldizli Ö, Kuhle J, Benedict RH
doi: 10.1177/1352458519881428.
Multiple Sclerosis
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
Brain
Barro C, Benkert P, Disanto G, Tsagkas C, Amann M, Naegelin Y, Leppert D, Gobbi C, Granziera C, Yaldizli Ö, Michalak Z, Wuerfel J, Kappos L, Parmar K, Kuhle J
doi: 10.1093/brain/awy154.
Multiple Sclerosis
Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
Mult Scler.
Siller N, Kuhle J, Muthuraman M, Barro C, Uphaus T, Groppa S, Kappos L, Zipp F, Bittner S
doi: 10.1177/1352458518765666.
Multiple Sclerosis
Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis
Eur J Neurol.
Boremalm M, Juto A, Axelsson M, Novakova L, Frisell T, Svenningsson A, Lycke J, Piehl F, Salzer J
doi: 10.1111/ene.13936.
Multiple Sclerosis
Serum neurofilament levels correlate with retinal nerve fiber layer thinning in multiple sclerosis
Mult Scler.
Bsteh G, Berek K, Hegen H, Teuchner B, Buchmann A, Voortman MM, Auer M, Wurth S, Zinganell A, Di Pauli F, Deisenhammer F, Khalil M, Berger T
doi: 10.1177/1352458519882279.
RECOMMENDED
Multiple Sclerosis
Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis
doi: 10.1001/jamaneurol.2018.4905.
Multiple Sclerosis
Serum neurofilament light: A biomarker of neuronal damage in multiple sclerosis
Ann Neurol.
Disanto G, Barro C, Benkert P, Naegelin Y, Schädelin S, Giardiello A, Zecca C, Blennow K, Zetterberg H, Leppert D, Kappos L, Gobbi C, Kuhle J; Swiss MS Cohort Study (SMSC) Group
doi: 10.1002/ana.24954.
SPECIAL REPORT
Multiple Sclerosis
Vaccination Readiness in Multiple Sclerosis
RECOMMENDED
Multiple Sclerosis
Neurofilament light levels are associated with long-term outcomes in multiple sclerosis
★ 3
Recommended by
Prof. Dr Christian Kamm, Faculty Member
Mult Scler.
Kuhle J, Plavina T, Barro C, Disanto G, Sangurdekar D, Singh CM, de Moor C, Engle B, Kieseier BC, Fisher E, Kappos L, Rudick RA, Goyal J
doi: 10.1177/1352458519885613.